Byrne Asset Management’s Medpace MEDP Stock Holding History

Byrne Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12	Closed	-$3K	–	562
2023 Q2	$3K	Hold	12	–	–	﹤0.01%	516
2023 Q1	$2K	Buy	+12	New	+$2.48K	﹤0.01%	554

Other funds holding MEDP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Byrne Asset Management's MEDP Position: Q3 2023 in Review

Byrne Asset Management sold out of Medpace (MEDP) in Q3 2023, closing a stake of 12 shares — an estimated $3K sold.

Byrne Asset Management first reported a position in MEDP in Q1 2023 and held it in 2 quarters. The position peaked at $3K in Q2 2023. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

Byrne Asset Management reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
Byrne Asset Management sold 12 Medpace shares in Q3 2023, an estimated $3K.
Byrne Asset Management first reported a position in Medpace in Q1 2023 and held it in 2 quarters.
Byrne Asset Management's Medpace position peaked at $3K in Q2 2023.
488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Byrne Asset Management's 13F filing for Q3 2023, filed 31 Oct 2023.